Hearing:
At What Cost: Oversight of How the IRA's Price Setting Scheme Means Fewer Cures for Patients
Subcommittee on Oversight and Investigations (Committee on Energy and Commerce)
Wednesday, September 20, 2023 (2:00 PM)
2123 RHOB
Washington, D.C.
Witnesses
John Crowley
Executive Chairman, Amicus Therapeutics, Inc.
Added
09/20/2023 at 09:29 AM
- Witness Statement
[PDF]
Added
09/20/2023 at 09:29 AM
- Witness Biography
[PDF]
Added
09/20/2023 at 09:29 AM
John Czwaratacki
Founder, Survivors for Solutions
Added
09/20/2023 at 09:29 AM
- Witness Statement
[PDF]
Added
09/20/2023 at 09:29 AM
- Witness Biography
[PDF]
Added
09/20/2023 at 09:29 AM
Dr. Aaron Kesselheim M.D., J.D., M.P.H.
Professor of Medicine, Harvard Medical School
Added
09/20/2023 at 09:29 AM
- Witness Statement
[PDF]
Added
09/20/2023 at 09:29 AM
- Witness Biography
[PDF]
Added
09/20/2023 at 09:29 AM
Dr. Steve Potts
Chair of the Drug Development Council, International Cancer Advocacy Network
Added
09/20/2023 at 09:29 AM
- Witness Statement
[PDF]
Added
09/20/2023 at 09:29 AM
- Witness Biography
[PDF]
Added
09/20/2023 at 09:29 AM
Support Documents
- Hearing Notice
[PDF]
- Hearing Memo
[PDF]
Added
09/20/2023 at 09:29 AM
First Published:
September 14, 2023 at 01:03 PM
Last Updated:
September 20, 2023 at 09:29 AM